Research Articles | Page 4 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
The Non-transplant Treatment of Myelodysplastic Syndromes-What's on the Horizon? Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndromes Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumab Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Overview of myelodysplastic syndromes Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Iron Overload Alters the Energy Metabolism in Patients With Myelodysplastic Syndromes: Results From the Multicenter FISM BIOFER Study Jun 2020 Scientific Reports myelodysplastic syndromes (MDS)